Canada

Keep up on what’s happening in the dementia patient and caregiver world throughout Canada.

Royal Ottawa Takes A Stand Against Antipsychotic Drugs

Royal Ottawa Takes A Stand Against Antipsychotic Drugs

by DON BUTLER

Fifteen care groups across Canada are taking part in a project aimed at reducing the amount of antipsychotic drugs given inappropriately to people with Alzheimer’s and dementia.

The Royal Ottawa Health Care Group—a mental health care centre in Ontario—is among the organizations participating in the project. It will work with the Peter D. Clark Long Term Care Home, one of four long-term care facilities it manages.

The project will focus on 99 of the facilities’ 216 beds, with the hope of cutting down on antipsychotic drug use by residents.

Participating groups are based in Newfoundland, British Columbia and Yukon, among other places.

According to the Ottawa Citizen, there are 7,500 long-term care home residents living in the Ottawa region. Almost one-third of them are taking antipsychotic drugs, even though they have not been diagnosed with psychosis.

Antipsychotic medication is often given to those with Alzheimer’s and dementia in order to control their aggression or agitation.

The issue was first brought to public attention in this country, after the Canadian Institute for Health Information questioned whether the high use of antipsychotic medication in long-term care facilities was appropriate.

Previous studies have found that those with Alzheimer’s and dementia show little improvement after being put on antipsychotic drugs. The medications have also been shown to have serious side effects, including leading to premature death.

The Canadian Geriatrics Society has advocated for a limited use of antipsychotic drugs among people with AD and dementia, saying the drugs should only been given in cases where other interventions are unsuccessful, and where the patient is a threat to themselves or others.

Funding for the initiative is being provided by the Canadian Foundation for Healthcare Improvement, a not-for-profit which receives money from the federal government, which is putting forth $750,000. The money will go towards adapting and putting into practice an approach used by the Winnipeg Regional Health Authority to cut antipsychotic drug use by 27 percent among a specific group of residents.



You might also enjoy:

The philosopher of care

Dr. Sholom Glouberman is the philosopher-in-residence at the Baycrest Centre for Geriatric Care in North…

Let me out! When hospital feels like jail

An elderly Victoria couple who have both been diagnosed with dementia say they are being held prisoner…

Spirit of the West's John Mann diagnosed with Alzheimer’s

Spirit of the West lead singer and guitarist John Mann has been diagnosed with early onset Alzheimer’s…

Take control: a program for early stage dementia

Over the past few months, the Murray Alzheimer Research and Education Program (MAREP) has been involved…

comments powered by Disqus